☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

BMJ criticises new ABPI Code of Practice

The Association of the British Pharmaceutical Industry's new Code of Practice for the Pharmaceutical Industry has been criticised in the British Medical Journal for "lacking teeth". The article is available online.

As already report, the new Code does not come into force until January 2006 but it has already been attacked for being "fundamentally weak" by the editor of the Drugs and Therapeutics Bulletin. Professor Andrew Herxheimer of the Cochrane Centre also stated that, "not much has changed".

Action: Despite the weaknesses of the new code Clinicians should be aware of the Code of Practice and also be prepared to make complaints to the Prescription Medicines Code of Practice Authority or the Medicines and Healthcare products Regulatory Agency.

Share 'BMJ criticises new ABPI Code of Practice' by emailShare 'BMJ criticises new ABPI Code of Practice' on FacebookShare 'BMJ criticises new ABPI Code of Practice' on TwitterShare 'BMJ criticises new ABPI Code of Practice' on MastodonShare 'BMJ criticises new ABPI Code of Practice' on LinkedInShare 'BMJ criticises new ABPI Code of Practice' on reddit

atomic-wealth

No Comments to “BMJ criticises new ABPI Code of Practice”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.